A number of BRAF fusions are, however, novel (Fig. 1, Supplementary Fig. 5), including ATG7–BRAF in melanoma, as well as ZC3HAV1–BRAF and FAM114A2–BRAF in thyroid cancer. Here, ATG7 is linked to thyroid gland carcinoma.